                               SEQUENCE LISTING

<110> THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
 
<120> PEPTIDE RECEPTOR RADIONUCLIDE THERAPY

<130> 070772-230210PC-1277009

<140> PCT/US2021/061886
<141> 2021-12-03

<150> 63/121,762
<151> 2020-12-04

<160> 7     

<170> PatentIn version 3.5

<210> 1
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
Gly Asn Gly Val Pro Asn Leu Arg Gly Asp Leu Gln Val Leu Gly Gln 
1               5                   10                  15      


Arg Val Gly Arg Thr 
            20      


<210> 2
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Leu or Ile

<400> 2
Arg Gly Asp Leu Xaa Xaa Xaa 
1               5           


<210> 3
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Arg or Lys

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Ala or Gly

<400> 3
Gln Xaa Val Xaa Arg Thr 
1               5       


<210> 4
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Gln Arg Val Gly Arg Thr 
1               5       


<210> 5
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Arg Gly Asp Leu Gln Val Leu Gly Gln Arg Val Gly Arg Thr 
1               5                   10                  


<210> 6
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Gly Asn Gly Val Pro Asn Leu Arg Gly Asp Leu Gln Val Leu Gly Gln 
1               5                   10                  15      


Arg Val Gly Arg Thr 
            20      


<210> 7
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
Gly Asn Gly Val Pro Asn Leu Arg Gly Asp Leu Gln Val Leu Gly Gln 
1               5                   10                  15      


Arg Val Gly Arg Thr 
            20      


